| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $7,484,775 ) |
| | 2025 | 2025 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | R01HL131836 | Structural Transition of Cellular Integrins and Applications Thereof | 001 | 9 | NIH | 12/26/2024 | $797,844 |
| | 2025 | 2025 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | P01HL151333 | Molecular and Clinical Glycobiology of the Bone Marrow Environment | 000 | 5 | NIH | 12/31/2024 | $2,213,925 |
| | 2025 | 2025 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | R01HL169144 | Interrogating clinically relevant attributes of maternal alloimmunity in fetal/neonatal alloimmune thrombocytopenia | 000 | 2 | NIH | 4/25/2025 | $420,866 |
| | 2025 | 2025 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | R01HL160861 | Kindlin-3 signaling in neutrophils | 000 | 4 | NIH | 1/27/2025 | $411,992 |
| | 2025 | 2025 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | R01HL157893 | Endothelial Rap1 in the control of heart function | 000 | 4 | NIH | 12/23/2024 | $664,924 |
| | 2025 | 2025 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | R01CA293588 | Therapeutic targeting of an oncogenic translational program in AML | 000 | 1 | NIH | 3/10/2025 | $545,170 |
| | 2025 | 2025 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | K01DK132453 | Defining the mechanisms of hemoglobin switching and genotoxicities associated with its manipulation | 002 | 4 | NIH | 3/31/2025 | $0 |
| | 2025 | 2025 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | R01CA257602 | Strategies to target BCR-ABL1 compound mutants in CML and Ph+ ALL | 000 | 5 | NIH | 12/6/2024 | $339,694 |
| | 2025 | 2025 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | R01HL161127 | B-cell response and thrombotic complications in COVID-19 | 000 | 4 | NIH | 3/4/2025 | $593,885 |
| | 2025 | 2025 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | R01CA268496 | The function of MS4A3 in normal and malignant hematopoiesis | 000 | 3 | NIH | 3/5/2025 | $425,749 |
| | 2025 | 2025 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | K01DK132453 | Defining the mechanisms of hemoglobin switching and genotoxicities associated with its manipulation | 001 | 4 | NIH | 3/5/2025 | $129,319 |
| | 2025 | 2025 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | K01DK132453 | Defining the mechanisms of hemoglobin switching and genotoxicities associated with its manipulation | 006 | 4 | NIH | 4/10/2025 | $17,565 |
| | 2025 | 2025 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | K01DK132453 | Defining the mechanisms of hemoglobin switching and genotoxicities associated with its manipulation | 006 | 4 | NIH | 4/10/2025 | $171,385 |
| | 2025 | 2024 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | R01HL166382 | Understanding and Controlling the Contribution of Fibrinolysis to Bleeding Using a Long-Acting Antifibrinolytic RNA Therapy | 000 | 2 | NIH | 3/19/2025 | $0 |
| | 2025 | 2024 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | R01HL089224 | Carbohydrate-Mediated Platelet Clearance | 000 | 16 | NIH | 12/19/2024 | $0 |
| | 2025 | 2024 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | R01HL166345 | CD39-carrying extracellular vesicles regulate pulmonary thrombosis in Sickle Cell Disease | 001 | 2 | NIH | 10/17/2024 | $789,466 |
| | 2025 | 2024 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | K99HL163412 | Pre-mRNA Processing and Function of Alternatively Spliced Isoforms of TFPI | 000 | 2 | NIH | 4/2/2025 | $0 |
| | 2025 | 2024 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | R35GM142926 | Investigating the regulation and substrate processing of ADAMTS13 and ADAMTS7 metalloproteases | 003 | 4 | NIH | 2/13/2025 | $31,034 |
| | 2025 | 2024 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | R35GM142926 | Investigating the regulation and substrate processing of ADAMTS13 and ADAMTS7 metalloproteases | 003 | 4 | NIH | 2/13/2025 | $58,967 |
| | 2025 | 2024 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | R01HL128297 | Pulmonary arteriole occlusion by platelet-neutrophil micro-emboli in Acute Chest Syndrome | 000 | 9 | NIH | 10/22/2024 | $0 |
| | 2025 | 2024 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | R35HL139937 | Basic Investigation and Translational Applications Concerning the Cell and Molecular Biology of Blood and Vascular Cells | 001 | 7 | NIH | 3/17/2025 | $0 |
| | 2025 | 2024 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | R35HL139937 | Basic Investigation and Translational Applications Concerning the Cell and Molecular Biology of Blood and Vascular Cells | 000 | 7 | NIH | 11/12/2024 | $0 |
| | 2025 | 2024 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | K08HL146941 | The role in inflammation in platelet activation and thrombosis | 000 | 5 | NIH | 4/30/2025 | $0 |
| | 2025 | 2023 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | F30CA246920 | Reprogramming tumor-reactive CD8 T cells by targeting the IL-21-BATF pathway to treat melanoma | 000 | 4 | NIH | 10/23/2024 | -$224 |
| | 2025 | 2023 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | R01HL131836 | Structural Transition of Cellular Integrins and Applications Thereof | 000 | 8 | NIH | 12/18/2024 | $0 |
| | 2025 | 2023 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | K01DK125617 | Molecular Mechanism of Sickle Cell Hepatic Crisis | 001 | 5 | NIH | 2/25/2025 | $608 |
| | 2025 | 2022 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | K12HL141954 | Glycans in Blood Homeostasis and Disease | 000 | 5 | NIH | 11/22/2024 | $0 |
| | 2025 | 2022 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | R01HL148120 | Molecular Basis of the Humoral Immune Response in Heparin-Induced Thrombocytopenia | 000 | 4 | NIH | 4/24/2025 | -$127,394 |
| | 2025 | 2022 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | R01HL068835 | Characterization of an isoform specific anticoagulant function of TFPI-alpha | 000 | 16 | NIH | 2/13/2025 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $18,346,029 ) (Continued on the next page) |
| | 2024 | 2024 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | R01CA254354 | Targeting the Metabolic Regulator SIRT5 in Acute Myeloid Leukemia | 001 | 6 | NIH | 6/27/2024 | $352,688 |
| | 2024 | 2024 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | R01HL128297 | Pulmonary arteriole occlusion by platelet-neutrophil micro-emboli in Acute Chest Syndrome | 001 | 9 | NIH | 6/14/2024 | $511,476 |
| | 2024 | 2024 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | R01HL128297 | Pulmonary arteriole occlusion by platelet-neutrophil micro-emboli in Acute Chest Syndrome | 004 | 9 | NIH | 7/8/2024 | $600,493 |
| | 2024 | 2024 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | R01HL068835 | Characterization of an isoform specific anticoagulant function of TFPI-alpha | 000 | 17 | NIH | 6/4/2024 | $763,919 |
| | 2024 | 2024 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | P01HL167668 | Molecular Mechanisms of Immune Thrombocytopenia in Transfusion Medicine | 000 | 1 | NIH | 7/31/2024 | $2,577,453 |
| | 2024 | 2024 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | P01HL167668 | Molecular Mechanisms of Immune Thrombocytopenia in Transfusion Medicine | 001 | 1 | NIH | 8/16/2024 | $0 |
| | 2024 | 2024 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | R01CA257602 | Strategies to target BCR-ABL1 compound mutants in CML and Ph+ ALL | 001 | 4 | NIH | 4/17/2024 | $18,872 |
| | 2024 | 2024 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | R01CA257602 | Strategies to target BCR-ABL1 compound mutants in CML and Ph+ ALL | 000 | 4 | NIH | 12/29/2023 | $339,694 |
| | 2024 | 2024 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | R35HL139937 | Basic Investigation and Translational Applications Concerning the Cell and Molecular Biology of Blood and Vascular Cells | 002 | 7 | NIH | 8/30/2024 | $0 |
| | 2024 | 2024 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | R35HL139937 | Basic Investigation and Translational Applications Concerning the Cell and Molecular Biology of Blood and Vascular Cells | 001 | 7 | NIH | 6/12/2024 | $78,926 |
| | 2024 | 2024 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | R35HL139937 | Basic Investigation and Translational Applications Concerning the Cell and Molecular Biology of Blood and Vascular Cells | 000 | 7 | NIH | 3/4/2024 | $887,912 |
| | 2024 | 2024 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | R01EY036588 | Endothelial Rap1 restricts inflammation in the retina | 000 | 1 | NIH | 9/11/2024 | $603,488 |
| | 2024 | 2024 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | K08HL146941 | The role in inflammation in platelet activation and thrombosis | 000 | 5 | NIH | 1/23/2024 | $162,043 |
| | 2024 | 2024 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | R01HL166382 | Understanding and Controlling the Contribution of Fibrinolysis to Bleeding Using a Long-Acting Antifibrinolytic RNA Therapy | 000 | 2 | NIH | 7/5/2024 | $707,172 |
| | 2024 | 2024 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | R01HL161127 | B-cell response and thrombotic complications in COVID-19 | 001 | 3 | NIH | 6/21/2024 | $52,790 |
| | 2024 | 2024 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | R01HL161127 | B-cell response and thrombotic complications in COVID-19 | 000 | 3 | NIH | 2/7/2024 | $593,885 |
| | 2024 | 2024 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | R01CA268496 | The function of MS4A3 in normal and malignant hematopoiesis | 000 | 2 | NIH | 12/21/2023 | $561,224 |
| | 2024 | 2024 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | K01DK125617 | Molecular Mechanism of Sickle Cell Hepatic Crisis | 002 | 6 | NIH | 5/28/2024 | $147,139 |
| | 2024 | 2024 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | R01CA268496 | The function of MS4A3 in normal and malignant hematopoiesis | 001 | 2 | NIH | 4/17/2024 | $31,180 |
|
